Skip to content

Cefotaxime Sodium EP Impurity B

Cefotaxime Sodium EP Impurity B

Product Description
CAT No.
ALN-C126003
CAS No.
66340-28-1
Mol. F.
C14H15N5O6S2
Mol. Wt.
413.4
Stock
Please Inquire
RFQ
Chemical Name : (6R,7R)-7-[[(2Z)-2-(2-Aminothiazol-4-yl)-2-(methoxyimino)acetyl]amino]-3-(hydroxymethyl)-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid (deacetylcefotaxime)
Smiles : O=C1N2[C@@](SCC(CO)=C2C(O)=O)([H])[C@]1([H])NC(/C(C3=CSC(N)=N3)=N\OC)=O
Inchi : InChI=1S/C6H12O6/c7-2-6(11)5(10)4(9)3(8)1-12-6/h3-5,7-11H,1-2H2/t3-,4?,5-,6?/m1/s1

Development and validation of stability indicating UFLC method for the estimation of Cefotaxime sodium and Diclofenac sodium in bulk and pharmaceutical dosage forms

By Koganti, Venkata Sairam; Thejaswini, J. Channabasappa; Chandan, Ravandur Shivanna; Bannimath, GurupadayyanFrom International Journal of Pharmaceutical Sciences Review and Research (2014), 25(1), 310-314, 5 pp..

Physical and chemical stability studies on cefotaxime and its dosage forms by stability indicating HPTLC method

By Behin, S.; Punitha, I. S. R.; Krishnan, S. – From International Journal of Pharmaceutical, Chemical and Biological Sciences (2012), 2(4), 517-523

Identification and characterization of new impurity in cefotaxime sodium drug substance

By Kumar, Vundavilli Jagadeesh; Gupta, Peruri Badarinadh; Pavan Kumar, K. S. R.; Prasada Rao, Korrapati V. V.; Prasanna, S. John; Siva Kumar, G. S.; Sharma, Hemant; Mukkanti, K. – From Pharma Chemica (2010), 2(3), 230-241

Request For Quotation

Related Products